Omission of Axillary Dissection After Nodal Downstaging With Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy
JAMA Oncol 2024 Apr 25;[EPub Ahead of Print], G Montagna, MM Mrdutt, SX Sun, C Hlavin, EJ Diego, SM Wong, AV Barrio, AB van den Bruele, N Cabioglu, V Sevilimedu, LH Rosenberger, ES Hwang, A Ingham, B Papassotiropoulos, BD Nguyen-Sträuli, C Kurzeder, DD Aybar, D Vorburger, DM Matlac, E Ostapenko, F Riedel, F Fitzal, F Meani, F Fick, J Sagasser, J Heil, H Karanlik, KJ Dedes, L Romics, M Banys-Paluchowski, M Muslumanoglu, MDRC Perez, MC Díaz, M Heidinger, MK Fehr, M Reinisch, M Tukenmez, N Maggi, N Rocco, N Ditsch, OD Gentilini, RR Paulinelli, SS Zarhi, S Kuemmel, S Bruzas, S di Lascio, TK Parissenti, TL Hoskin, U Güth, V Ovalle, C Tausch, HM Kuerer, AS Caudle, JF Boileau, JC Boughey, T Kühn, M Morrow, WP WeberFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.